Wondering if this relates to the cures companies have been sitting on:
Verzenio could become Lilly’s biggest oncology winner: The company reported overwhelmingly positive results earlier this month from a phase 3 study of the drug as a treatment for early-stage breast cancer. Lilly also recently won FDA approval for Retevmo in treating lung and thyroid cancer. In addition, the company’s pipeline includes promising late-stage candidates targeting osteoarthritic pain, atopic dermatitis, and psoriasis.
https://www.fool.com/investing/2020/06/27/3-top-pharma-stocks-to-buy-in-a-recession.aspx